Results 191 to 200 of about 20,268 (224)

Prevalence of Tricuspid Regurgitation and Mortality Outcomes in Patients With Heart Failure: Stratification by Phenotype. [PDF]

JACC Adv
Mattig I, Romero Dorta E, Frumkin D, Kretzschmar H, Sommer A, Redel AM, Buchstaller J, Stangl K, Hindricks G, Dreger H.   +9 more
europepmc   +1 more source

Predicting ICU admission in geriatric hip fracture patients with heart failure: the role of O-POSSUM and heart failure subtypes. [PDF]

BMC Geriatr
Bayındır S, Kazez M, Yalın M.
europepmc   +1 more source

Clusterin protects against HFpEF by inhibiting UCHL1-mediated NLRP3 deubiquitylation and inflammasome activation. [PDF]

Front Pharmacol
Yu J, Kang X, Chang R, Zhang C, Yang S, Chen L, Wang X, Hu B, Wang Z, Gong L, Liu L.   +10 more
europepmc   +1 more source

HFA-PEFF score as a predictor of worsening heart failure after first-time catheter ablation for atrial fibrillation in patients with preclinical heart failure and preserved ejection fraction. [PDF]

Front Cardiovasc Med
Hirayama S, Fujiki S, Maekawa A, Sato S, Ikesugi H, Tanaka K, Sekiya Y, Tsuchiya H, Kumaki T, Suzuki N, Sakai R, Ikami Y, Hasegawa Y, Otsuki S, Kayamori H, Takayama T, Kashimura T, Inomata T.   +17 more
europepmc   +1 more source

Invasive Diagnosis of HFpEF and ANOCA in a Patient With Effort Dyspnea and Angina. [PDF]

JACC Case Rep
Forzano I, Gargiulo G, Manzi L, Avvedimento M, Narciso V, Ciaramella L, Di Serafino L, Esposito G.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Myocardial Metabolic Reprogramming in HFpEF

Journal of Cardiovascular Translational Research, 2023
Heart failure (HF) caused by structural or functional cardiac abnormalities is a significant cause of morbidity and mortality worldwide. While HF with reduced ejection fraction (HErEF) is well understood, more than half of patients have HF with preserved ejection fraction (HFpEF).
Zihui Zhang, Mingchu Sun, Wenhua Jiang, Lu Yu, Chan Zhang, Heng Ma   +5 more
openaire   +2 more sources

Sex Differences in HFpEF

Current Treatment Options in Cardiovascular Medicine, 2020
Heart failure with preserved ejection fraction (HFpEF) disproportionately affects women. Though no unifying theory exists to explain this phenomenon, the purpose of this review is to explore the many factors that likely contribute to this female predominance.
Anna C. O’Kelly, Emily S. Lau
openaire   +1 more source

HFpEF treatment: pharmacological therapy

2018
Heart failure with preserved ejection fraction (HFpEF) is a diverse syndrome characterized by signs and symptoms of heart failure with relatively preserved ejection fraction. Despite the established efficacy of numerous classes of drugs and devices in heart failure with reduced ejection fraction, no specific therapy has yet proven to reduce morbidity ...
Maja Cikes, Scott D. Solomon
openaire   +1 more source

Istaroxime in HFpEF

JACC: Heart Failure, 2023
Ryan J. Tedford, Daniel N. Silverman
openaire   +1 more source